Upstream Bio Net Worth 1971-1970 | UPB

Upstream Bio net worth as of October 22, 2024 is $1.33B.

Interactive chart of historical net worth (market cap) for Upstream Bio (UPB) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding.

Upstream Bio Net Worth 1971-1970 | UPB

Interactive chart of historical net worth (market cap) for Upstream Bio (UPB) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding.
Related Stocks
Company NameMarket
Cap
Amgen (AMGN)$170.2B
Vertex Pharmaceuticals (VRTX)$123.4B
Gilead Sciences (GILD)$107.4B
Regeneron Pharmaceuticals (REGN)$106.8B
Bristol Myers Squibb (BMY)$105.7B
CSL (CSLLY)$97.7B
GSK (GSK)$79.1B
Alnylam Pharmaceuticals (ALNY)$37.5B
Argenex SE (ARGX)$33.5B
Biogen (BIIB)$26.9B
BioNTech SE (BNTX)$26.5B
Illumina (ILMN)$23.1B
BeiGene (BGNE)$21.4B
Moderna (MRNA)$20.7B
Genmab (GMAB)$15.1B
BioMarin Pharmaceutical (BMRN)$13.3B
Vaxcyte (PCVX)$12.9B
Exact Sciences (EXAS)$12.8B
Incyte (INCY)$12.6B
Insmed (INSM)$12.4B
Sarepta Therapeutics (SRPT)$12.1B
Bio-Techne Corp (TECH)$11.2B
QIAGEN (QGEN)$9.6B
Bio-Rad Laboratories (BIO.B)$9.3B
Roivant Sciences (ROIV)$8.6B
Repligen (RGEN)$8.4B
Exelixis (EXEL)$8.2B
Intra-Cellular Therapies (ITCI)$8.1B
Revolution Medicines (RVMD)$8B
Legend Biotech (LEGN)$7.9B